aTyr Pharma, Inc. (ATYR) financials · rev $190.0K
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
aTyr Pharma, Inc. (ATYR) rev $190.0K.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $190.00K | $235.00K | |
| Operating Income | −$77.63M | −$67.91M | |
| Net Income | −$74.12M | −$64.02M | |
| EPS (Diluted) | −$0.80 | −$0.86 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $93.00M | $96.83M | |
| Current Assets | $80.24M | $81.95M | |
| Cash & Equivalents | $10.74M | $11.05M | |
| PP&E | $4.26M | $4.85M | |
| Total Liabilities | $25.52M† | $26.81M† | |
| Current Liabilities | $15.15M | $14.97M | |
| Shareholders' Equity | $67.48M | $70.02M | |
| Retained Earnings | −$606.16M | −$532.05M |
† Total Liabilities: Derived: total assets minus shareholders’ equity (stored total liabilities equalled total assets, i.e. the liabilities-and-equity total).
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$61.99M | −$69.12M | |
| CapEx | $77.00K | $65.00K | |
| Investing Cash Flow | −$5.05M | $17.23M | |
| Financing Cash Flow | $66.01M | $39.86M | |
| Net Change in Cash | −$1.03M | −$12.02M | |
| Free Cash Flow | −$62.06M | −$69.18M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is ATYR P/E and revenue?
aTyr Pharma, Inc. (ATYR) rev $190.0K.
What is ATYR revenue?
aTyr Pharma, Inc. last cached revenue is $190.0K (FY2025).
Is ATYR profitable?
aTyr Pharma, Inc. last cached net income is -$74.1M (FY2025).
What are ATYR total assets?
aTyr Pharma, Inc. last cached total assets are $93.0M (FY2025).
What is ATYR free cash flow?
aTyr Pharma, Inc. last cached free cash flow is -$62.1M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.